Abstract
Many diabetes patients, especially the elder ones, suffered from hypertension simultaneously. Therefore, it is very likely that a large number of diabetes patients receiving metformin hydrochloride may simultaneously be given beta-blockers. Knowing that both metformin and atenolol are eliminated by organic cation transporter 2 (OCT2/SLC22A2) expressed in the renal basolateral membrane, it is not clear whether there is a competitive effect on the renal excretion of metformin and/or atenolol when metformin and atenolol were co-administered, and whether age was involved in this drug–drug interaction. In this present study, both young rats (aged 3 months) and aged rats (aged 12 months) were used, rats were divided into metformin-treated group and metformin and atenolol co-administrated group, respectively. Either metformin (2.5 mg/kg) alone or metformin (2.5 mg/kg) in combination with atenolol (8 mg/kg) was administered to rats by tail vein injection. Then, urine was collected and the metformin concentration in urine was determined by HPLC. The localization and expression of rOCT2 in kidney were also investigated by Western blotting and immunohistochemistry. Significant differences of t 1/2, K e, CLtot and the accumulated metformin excretion in urine were founded in aged rats, but not in young rats, between metformin-treated group (2.002 ± 0.51 h, 0.346 ± 0.07/h, 57.161 ± 18.59 %, 4,287.087 ± 458.08 μg) and metformin plus atenolol-treated group (3.03 ± 0.67 h, 0.228 ± 0.05/h, 43.199 ± 10.28 %, 3,239.972 ± 446.61 μg). Moreover, a significant age-related decrease in rOCT2 protein expression was observed in the aged rats (P < 0.01), which may be responsible for the effect of atenolol on the renal excretion of metformin in the aged rats. In conclusion, there is a drug-drug interaction between atenolol and metformin, and more attention should be paid when atenolol and metformin were co-administered to the aged people inclinical.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bachmakov I, Glaeser H, Endress B, Morl F, Konig J, Fromm MF (2009) Interaction of beta-blockers with the renal uptake transporter OCT2. Diabetes Obes Metab 11(11):1080–1083
Davies DF, Shock NW (1950) Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29(5):496–507
de Leeuw PW, Birkenhäger WH (1983) Renal effects of beta blockade in essential hypertension. Eur Heart J 4(Suppl D):13–17
Ding Y, Jia YY, Song Y, Lu CT, Li YW, Chen MC, Wang MM, Wen AD (2014) The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects. Eur J Clin Pharmacol 70:141–146
Dudley AJ, Bleasby K, Brown CDA (2000) The organic cation transporter OCT2 mediates the uptake of β-adrenoceptor antagonists across the apical membrane of renal LLC-PK1 cell monolayers. Br J Pharmacol 131:71–79
Epstein M, Oster JR, Hollenberg NK (1985) Beta-blockers and the kidney: implications for renal function and renin release. Physiologist 28(1):53–63
Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care (2006) Diabet Med 23(6):579–593
Gorina Y, Lentzner H (2008) Multiple causes of death in old age. Aging Trends 9:1–9
Jin HE, Hong SS, Choi MK, Maeng HJ, Kim DD, Chung SJ, Shim CK (2009) Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis. Pharm Res 26(3):549–559
Kimura N, Okuda M, Inui K (2005) Metformin transport by renal basolateral organic cation transporter hOCT2. Pharm Res 22(2):255–259
Leeman M, van de Borne P, Collart F, Vandenhoven G, Peeters L, Mélot C, Degaute JP (1993) Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure. J Cardiovasc Pharmacol 22(6):785–791
Mooradian AD (1997) Central nervous system complications of diabetes mellitus—a perspective from the blood–brain barrier. Brain Res Brain Res Rev 23(3):210–218
National Diabetes Data Group (U.S.), National Institute of Diabetes and Digestive and Kidney Diseases (U.S.), National Institutes of Health (U.S.) (1995) Diabetes in America. NIH publication no. 95-1468, 2nd edn. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 (2011) Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta, GA
Romagnoli F (2003) Diabetes and non-traumatic lower extremity amputation in a region of central Italy. Diabetes Nutr Metab 16:155–159
Saeki J, Sekine S, Horie T (2011) LPS-induced dissociation of multidrug resistance-associated protein 2 (Mrp2) and radixin is associated with Mrp2 selective internalization in rats. Biochem Pharmacol 81(1):178–184
Sambol NC, Chiang J, Lin ET, Goodman AM, Liu CY, Benet LZ, Cogan MG (1995) Kidney function and age are both predictors of pharmacokinetics of metformin. J Clin Pharmacol 35:1094
The use of medicines in the United States: review of 2010 (2010) IMS Institute for Healthcare Informatics, Parsippany
Tsai C, Hayes C, Taylor GW (2002) Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 30(3):182–192
Umehara KI, Iwatsubo T, Noguchi K, Kamimura H (2008) Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats. J Int Med Res 36(1):123–136
Urakami Y, Okuda M, Masuda S, Akazawa M, Saito H, Inui K (2001) Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules. Pharm Res 18(11):1528–1534
Wilkinson R (1982) Beta-blockers and renal function. Drugs 23(3):195–206
Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K (2007) Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol 74(3):477–487
Zhang T, Han S, Huang J, Wang S (2013) Combined fibroblast growth factor receptor 4 cell membrane chromatography online with high performance liquid chromatography/mass spectrometry to screen active compounds in Brassica albla. J Chromatogr B Analyt Technol Biomed Life Sci 912:85–92
Acknowledgments
This research was supported by the Department of Pharmacy, First Hospital of Lanzhou University.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ren, J., Zhou, Y., Zhang, G. et al. Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats. Eur J Drug Metab Pharmacokinet 40, 349–354 (2015). https://doi.org/10.1007/s13318-014-0214-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13318-014-0214-9